Arax Advisory Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-103
Closed -$571 3030
2024
Q4
$571 Buy
+103
New +$571 ﹤0.01% 2305